Catch up with the OASPA 2020 Conference: recordings available
Find out more about what was covered at this year’s online conference of the Open Access Scholarly Publishing Association (OASPA).
Meeting report: summary of session 1 of the 8th EMWA Symposium
Missed the meeting? Read our report on the symposium entitled “Research integrity & the medical communicator: what we do when no one is watching.”
Predatory journal ‘safelists’ and ‘watchlists’: who decides?
Learn how predatory journals are identified, and why journal ‘watchlists’ and ‘safelists’ have their own pitfalls.
2020 International Open Access Week is here!
Find out more about the events taking place this Open Access Week, themed ‘Open with purpose: taking action to build structural equity and inclusion’.
How research can be shared effectively to advance science: insights from the Center for Open Science
David Mellor from the Center for Open Science explains how the company is supporting and facilitating the open science movement.
Researchers call for better adoption of open science in COVID-19 research
Researchers identify flaws in current COVID-19 research and publication processes, and provide solutions using Open Science principles
Academics’ access to journals: it’s no longer a ‘big deal’
‘Little deals’ are replacing large scale journal subscriptions. But how is this changing purchasing landscape impacting libraries and their users?
Opportunities and challenges in open access publishing of industry-sponsored research
Medical Publishing Insights and Practices (MPIP) initiative members share perspectives on the benefits of publishing industry-sponsored research open access.
COVID-19 sparks rapid change in the medical research landscape
COVID-19 has had an unprecedented global impact. Now, a Digital Science report asks how the research landscape has adapted to these extreme circumstances.
Open access publishing of pharma-sponsored research: insights from a Scientific Publications Lead
Slávka Baróniková shares her opinions on open access publishing and suggests how this can be successfully achieved within pharma.
[PODCAST] Open access: opportunities and challenges
Listen to Kristen Ratan discuss the benefits and challenges of open access.
As science looks to adapt to the COVID-19 pandemic, the need to publish with transparency, speed and openness is ever greater
The increasing range of publication choices and demand for open access are explored in this sponsored article from Taylor & Francis Group.
cOAlition S bypass a block on the road to open access
cOAlition S Rights Retention Strategy aims to safeguard researchers’ intellectual ownership, enabling embargo-free sharing of research in online repositories.
Journal citation counts increase despite discontinuation from Scopus
Analysis of metrics for journals discontinued from Scopus for publication concerns highlights a need for clearer warnings on articles from such journals.
Journal open access cost breakdowns will be needed for cOAlition S support
From 2022, journals will need to follow cOAlition S price transparency requirements to get paid. Find out more about the frameworks and potential benefits here.
cOAlition S publishes updated criteria for hybrid journals transitioning to open access
Following a public consultation, updated cOAlition S guidance relaxes the criteria for transformative journals, prompting commitments from further journals.